Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in recent ...

Hologic received a warning letter in December from the Food and Drug Administration related to safety concerns with the company’s Biozorb implantable radiographic markers. The FDA found that ...

As the first FDA-approved mammography technology, the Envision platform enhances the detection of subtle objects, minimizes focal spot blur and improves 3D image sharpness. Furthermore ...

Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in ...

The most recent trading session ended with Hologic (HOLX) standing at $72.73, reflecting a +0.05% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...